Viking Therapeutics (VKTX) Misses Q1 EPS by 8c

Viking Therapeutics (NASDAQ: VKTX) reported Q1 EPS of ($0.41), $0.08 worse than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
• Walhalla Gold names Lisa Gibbons to its board of directors
• TurboGen posts H1 2026 loss of $4.2M, lists on Nasdaq